Abstract
Randomized clinical trials have become a major tool in the process of evaluating the benefits of new treatments or other interventions. One principal reason for this is that well-designed randomized trials can avoid the problems of bias, which might arise due to patient selection. The issues concerning these trials are largely cluster-randomized trials have become increasingly common, in both palliative medicine and diverse other health research areas. Cluster-randomized trials are characterized by the randomization of groups -clusters - of patients rather than individuals, and may offer many major advantages but also involve several particular considerations.
Original language | English |
---|---|
Pages (from-to) | 69-70 |
Number of pages | 2 |
Journal | Palliative Medicine |
Volume | 16 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jan 2002 |